Literature DB >> 32095924

Evaluation of Long-Term Satisfaction with Breast Surgery in Patients Treated for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.

Devon Livingston-Rosanoff1, Amy Trentham-Dietz2, John M Hampton2, Polly A Newcomb3, Lee G Wilke4.   

Abstract

BACKGROUND: Breast-conserving surgery (BCS) and mastectomy have equivalent survival for ductal carcinoma in situ (DCIS), allowing patients to participate in selecting a personalized surgical option; however, this decision-making role can increase patient anxiety. Data evaluating patient satisfaction with their decision to undergo BCS versus mastectomy for the treatment of DCIS are limited.
METHODS: Women with DCIS were enrolled in a population-based, state-wide cohort from 1997 to 2006. Participants were surveyed about their satisfaction with their surgical and reconstruction decisions. Quality-of-life (QoL) evaluations were performed with biennial follow-up surveys though 2016. Multivariable logistic regression modeling examined the relationship between type of surgery and reconstruction with patient satisfaction.
RESULTS: Overall, 1537 women were surveyed, on average, 2.9 years following DCIS diagnosis. Over 90% reported satisfaction with their treatment decision regardless of surgery type. Women who underwent mastectomy with reconstruction were more likely to report lower levels of satisfaction than women who underwent BCS (odds ratio [OR] 2.98, 95% confidence interval [CI] 1.18-7.51, p < 0.01). However, over 80% of women who underwent mastectomies reported satisfaction with their reconstruction decision. Women without reconstruction had the highest levels of satisfaction, while women with implants were more likely to be dissatisfied (implant + autologous: OR 2.77, 95% CI 1.24-6.24; implant alone: OR 4.02, 95% CI 1.947-8.34, p ≤ 0.01). QoL scores were not associated with differences in surgical or reconstruction satisfaction at 5, 10, and 15 years following DCIS diagnosis.
CONCLUSIONS: Women undergoing surgery for DCIS express satisfaction with their treatment decisions. Following mastectomy, most women are satisfied with their reconstruction decision, including women who did not undergo reconstruction.

Entities:  

Mesh:

Year:  2020        PMID: 32095924      PMCID: PMC7338253          DOI: 10.1245/s10434-020-08216-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

1.  Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer.

Authors:  Paula M Lantz; Nancy K Janz; Angela Fagerlin; Kendra Schwartz; Lihua Liu; Indu Lakhani; Barbara Salem; Steven J Katz
Journal:  Health Serv Res       Date:  2005-06       Impact factor: 3.402

2.  Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ.

Authors:  Oyewale O Shiyanbola; Brian L Sprague; John M Hampton; Kim Dittus; Ted A James; Sally Herschorn; Ronald E Gangnon; Donald L Weaver; Amy Trentham-Dietz
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

3.  Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image.

Authors:  H Sackey; K Sandelin; J Frisell; M Wickman; Y Brandberg
Journal:  Eur J Surg Oncol       Date:  2010-07-03       Impact factor: 4.424

4.  Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Hazel B Nichols; John M Hampton; Polly A Newcomb
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

5.  Cosmesis outcomes for sector resection for ductal carcinoma in situ (DCIS).

Authors:  Beverley Fosh; Alison Hainsworth; Jesse Beumer; Benjamin Howes; William McLeay; Michael Eaton
Journal:  Ann Surg Oncol       Date:  2014-01-01       Impact factor: 5.344

6.  Does patient satisfaction with breast reconstruction change over time? Two-year results of the Michigan Breast Reconstruction Outcomes Study.

Authors:  Amy K Alderman; Latoya E Kuhn; Julie C Lowery; Edwin G Wilkins
Journal:  J Am Coll Surg       Date:  2006-11-16       Impact factor: 6.113

7.  Are patients with breast cancer satisfied with their decision making?: a comparison over time.

Authors:  Jane E Lacovara; Jill Arzouman; Christina J Kim; Janice A Degan; Margaret Horner
Journal:  Clin J Oncol Nurs       Date:  2011-06       Impact factor: 1.027

8.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

9.  Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Vicki Hart; Brian L Sprague; Susan G Lakoski; John M Hampton; Polly A Newcomb; Ronald E Gangnon; Amy Trentham-Dietz
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

10.  Correlates of patient satisfaction and provider trust after breast-conserving surgery.

Authors:  Jennifer F Waljee; Emily S Hu; Lisa A Newman; Amy K Alderman
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

View more
  2 in total

Review 1.  Invited Discussion on: The Impact of Reconstructive Modality and Postoperative Complications on Decision Regret and Patient-Reported Outcomes following Breast Reconstruction.

Authors:  Luís Ricardo Martinhão Souto
Journal:  Aesthetic Plast Surg       Date:  2022-01-15       Impact factor: 2.708

2.  The double S technique to achieve aesthetic flat closure after conventional mastectomy.

Authors:  Daniel Steffens; Elisabeth A Kappos; Alexander Lunger; Fabienne D Schwab; Lea Zehnpfennig; Walter Paul Weber; Martin Haug; Viola Heinzelmann-Schwarz; Christian Kurzeder
Journal:  World J Surg Oncol       Date:  2022-02-21       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.